Amicus Therapeutics Inc (NASDAQ:FOLD)

Delayed Data
As of 3:59pm ET
 -0.09 / -0.83%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 9 analysts offering 12-month price forecasts for Amicus Therapeutics Inc have a median target of 16.00, with a high estimate of 29.00 and a low estimate of 12.00. The median estimate represents a +48.70% increase from the last price of 10.76.

Analyst Recommendations

The current consensus among 11 polled investment analysts is to Buy stock in Amicus Therapeutics Inc. This rating has held steady since September, when it was upgraded from a Hold rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Nov 08

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 7.52%
Growthannually 25.02%


Growthquarterly 3.49%
Growthannually 18.94%
Key to the earnings and sales forecast charts.